Ask AI

Advancing Pharmacist Excellence in RRMM: Optimizing Bispecific Antibody Selection, Safety, and Patient Care

Develop a deeper understanding of bispecific antibodies used to treat relapsed/refractory multiple myeloma based on recent clinical trial data and guideline recommendations to personalize treatment and manage associated toxicities through certified downloadable slides, certified text modules, an expert-authored ClinicalThought commentary, and audio podcast.

Share

Program Content

Events

  • Live Event
    Advancing Pharmacist Excellence in RRMM: Optimizing Bispecific Antibody Selection, Safety, and Patient Care
    Congratulations: You achieved a completion on 04/09/2022

    You can enroll in the following live event(s) on this topic.

  • Live Event
    Advancing Pharmacist Excellence in RRMM: Optimizing Bispecific Antibody Selection, Safety, and Patient Care
    Congratulations: You achieved a completion on 04/09/2022

    You can enroll in the following live event(s) on this topic.

Activities

Pharmacist Excellence in RRMM
Advancing Pharmacist Excellence in RRMM: Optimizing Bispecific Antibody Selection, Safety, and Patient Care
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 20, 2026

Provided by

ProCE Banner

Provided by ProCE, LLC.

Supporters

Supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc